American Testosterone Clinic for Men

Reading Time: 2 minutesLipocine Inc. (www.lipocine.com), a biopharmaceutical company focused on developing innovative oral hormone therapies for mens and womens health, today announced favorable Phase I results for LPCN 1111. LPCN 1111, a novel prodrug of testosterone, uses the Companys proprietary Lipral technology to enhance solubility and improve absorption during testosterone replacement therapy. Data from the Phase I study established that LPCN 1111 exhibited a strong safety profile and pharmacokinetics which should allow for once-a-day dosing of this next-generation oral testosterone replacement product. The LPCN 1111 development program complements Lipocines robust pipeline of potential products including LPCN 1021, a twice-daily oral testosterone replacement, … Read more »

Reading Time: 2 minutesHouston,TX, Aug. 14, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (SMMR) is pleased to announce the acquisition from a Houston, PhD led Biomedical research firm, all work product, rights, and interest in the "Inducible Expression System for Biosynthetic Production of Testosterone in Men" being developed by them. With this ground breaking technology, Symmetry Technologies Inc, is creating an inducible expression system that acts as a molecular "switch" to turn on particular enzymes that are key in the body's natural biosynthetic pathway of free testosterone production without the need to administer artificial steroids. This "switch" can be turned on by simple … Read more »

Reading Time: 2 minutesOAKLAND, Calif., Jan. 31, 2013 -- Low testosterone levels occur five times more often among men who take long-acting instead of short-acting opioids for chronic pain, according to a new Kaiser Permanente study published in The Clinical Journal of Pain. While it has been known that opioids cause low testosterone in men, this study is the first to show a significant difference in risk between short-acting (immediate release) and long-acting opioids. The 81 men in the retrospective study were between 26 and 79 years old (median age 51) and were seen in the chronic-pain clinic at Kaiser Permanente's Santa Rosa … Read more »

Reading Time: 2 minutes(Reuters) - Repros Therapeutics Inc said U.S. health regulators agreed with its plan to continue analyzing data from a late-stage study of its experimental testosterone drug, putting the company on track to report trial data in the third quarter and sending its shares up 45 percent. The company last month pushed back the expected date to report data from the first of two late-stage studies on its drug Androxal after it found that the patient population at a site where the drug was being tested was markedly different from 16 other sites. Repros said at the time that it expected … Read more »

Reading Time: 2 minutesUsing a testosterone gel in addition to Viagra doesn't make the little blue pill work any better, according to a US study. Studies have suggested that about one-quarter to one-third of men with erectile dysfunction, or ED, also have low testosterone, and the authors of the study - which appeared in the Annals of Internal Medicine - say that a starting course of sildenafil citrate, marketed as Viagra, helped improve sexual function for men with both conditions. But adding testosterone, typically prescribed to men who have both low testosterone levels and symptoms such as little interest in sex or low … Read more »

Reading Time: < 1 minuteTIME Health Research Low Testosterone Levels Are Not the Cause of Less Sex but the Result of It Getty Images So says a new study conducted on a large group of older men in Australia Its normally thought that lower testosterone levels in older men lead to less appetite for sex. However, an intriguing new study from Australia finds that a decline in testosterone levels appears to be the result of a lower libido. Thats according to a report in Science Daily. In older men, decreased sexual activity and desire may be a cause, not an effect, of low circulating … Read more »

Reading Time: 2 minutesContact Information Available for logged-in reporters only Newswise San Diego, CAMen with borderline testosterone levels have higher rates of depression and depressive symptoms than the general population, new research finds. The results will be presented Saturday, March 7, at ENDO 2015, the annual meeting of the Endocrine Society in San Diego. Over half of men referred for borderline testosterone levels have depression. This study found that men seeking management for borderline testosterone have a very high rate of depression, depressive symptoms, obesity and physical inactivity, said principal study author Michael S. Irwig, MD, FACE, associate professor of medicine and director … Read more »

Reading Time: 2 minutesTestosterone is a hormone that carries out important work in our remarkable human bodies, but after the age of 30 or so men's testosterone levels begin to get lower and continue to do so throughout the following years. Even though this is a normal process of the body the sad fact is that these testosterone levels decrease more drastically for some than for others, causing problems within their bodies. While it seems that the majority of men who suffer from low testosterone are older, younger men and even teenage males can suffer from this condition as wel Causes and Who … Read more »